ClinicalTrials.Veeva

Menu

FGF-21 and Exercise in Relation to Insulin Secretion

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Physical Activity

Treatments

Other: spiroergometry

Study type

Interventional

Funder types

Other

Identifiers

NCT02667964
FGF-Exercise

Details and patient eligibility

About

FGF-21 and insulin are key hormones in the regulation of glucose metabolism. Furthermore, both hormones are influenced by physical activity. The following hypothesis will be tested: FGF-21 is regulated insulin-dependent during exercise.

Full description

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by rising global importance. In Germany alone, more than seven million people are being treated currently. T2DM is characterized by permanently elevated blood glucose levels, based on insulin resistance and followed by associated beta cell failure. In our previous work the investigators could already shown that increased FGF-21 levels are accompanied by an increased risk of T2DM. Physical activity is essential in the treatment and the prevention of T2DM. Interestingly, it was shown that acute physical exercise was leading to decreased insulin levels and increased FGF-21 values. In this study the effects of acute physical activity on FGF-21 values should be investigated in 3 groups: a) Healthy volunteers b) persons with T2DM c) persons with T1DM.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy volunteers,persons with T2DM, persons with T1DM

Exclusion criteria

  • Patients with contraindications to an exercise ECG or spirometry be excluded from participation in the study.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 3 patient groups

Healthy controls
Other group
Description:
Spiroergometry
Treatment:
Other: spiroergometry
Patients with T2DM
Other group
Description:
Spiroergometry
Treatment:
Other: spiroergometry
Patients with T1DM
Other group
Description:
Spiroergometry
Treatment:
Other: spiroergometry

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Bobbert, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems